Liming Wang
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
Papers in
- Hepatology 19
- Hepatocellular Carcinoma Treatment and Prognosis 18
-
- Vitamin D Research Studies 2
- Genetic factors in colorectal cancer 2
- Cancer Mechanisms and Therapy 2
- Co-authors
- Jianxiong Wu (24 shared papers)Fan Wu (16 shared papers)Weiqi Rong (19 shared papers)Weihu Wang (9 shared papers)Bo Chen (7 shared papers)Weibo Yu (8 shared papers)Quan Xu (2 shared papers)Shengtao Lin (5 shared papers)
- Journals
- Oncotarget (4 papers)Molecular Carcinogenesis (3 papers)eLife (2 papers)Tumor Biology (2 papers)Medical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Liming Wang
59 papers receiving 1.4k citations
Liming Wang's Hit Papers
Peers
Comparison fields: 5 of 94
- Hepatology 549
- Cardiology and Cardiovascular Medicine 224
- Oncology 199
- Cancer Research 97
- Pathology and Forensic Medicine 103
Countries citing papers authored by Liming Wang
This map shows the geographic impact of Liming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Wang more than expected).
Fields of papers citing papers by Liming Wang
This network shows the impact of papers produced by Liming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Wang. The network helps show where Liming Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liming Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2023 | 362 |
| 2 | Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation Hit paper breakdown → | 2020 | 269 |
| 3 | 2021 | 62 | |
| 4 | 2013 | 54 | |
| 5 | 2017 | 47 | |
| 6 | 2021 | 47 | |
| 7 | CCR6+ B lymphocytes responding to tumor cell-derived CCL20 support hepatocellular carcinoma progression via enhancing angiogenesis. | 2017 | 41 |
| 8 | 2022 | 32 | |
| 9 | 2017 | 31 | |
| 10 | 2024 | 31 | |
| 11 | 2017 | 26 | |
| 12 | 2019 | 22 | |
| 13 | 2019 | 20 | |
| 14 | 2013 | 20 | |
| 15 | 2020 | 18 | |
| 16 | 2016 | 18 | |
| 17 | 2013 | 17 | |
| 18 | 2022 | 16 | |
| 19 | 2013 | 15 | |
| 20 | 2015 | 15 |
About Liming Wang
Liming Wang is a scholar working on Hepatology, Pathology and Forensic Medicine, Surgery, Oncology and Immunology, having authored 63 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), RNA modifications and cancer (3 papers), Immune Cell Function and Interaction (3 papers), Vitamin D Research Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer Mechanisms and Therapy (2 papers) and Poxvirus research and outbreaks (2 papers). The work is most often cited by research in Hepatology (549 citations), Cardiology and Cardiovascular Medicine (224 citations), Oncology (199 citations), Cancer Research (97 citations) and Pathology and Forensic Medicine (103 citations). Liming Wang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Jianxiong Wu, Fan Wu, Weiqi Rong, Weihu Wang, Bo Chen, Weibo Yu, Quan Xu, Shengtao Lin, Ye‐Xiong Li and Liguo Liu. Their work appears in journals such as Oncotarget, Molecular Carcinogenesis, eLife, Tumor Biology and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.